# Comparative Efficacy Study to Demonstrate the Non-inferiority of I-DROP® MGD Versus 2 Competitor Eye Drops in Managing Evaporative Dry Eye

> **NCT06686368** · PHASE4 · NOT_YET_RECRUITING · sponsor: **I-MED Pharma** · enrollment: 60 (estimated)

## Conditions studied

- Evaporative Dry Eye Disease

## Interventions

- **DEVICE:** I-DROP MGD
- **DEVICE:** Theloze Duo
- **DEVICE:** Systane Complete PF

## Key facts

- **NCT ID:** NCT06686368
- **Lead sponsor:** I-MED Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-15
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06686368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06686368, "Comparative Efficacy Study to Demonstrate the Non-inferiority of I-DROP® MGD Versus 2 Competitor Eye Drops in Managing Evaporative Dry Eye". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06686368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*